Product Information
GNP ANTIBIOTIC-PAIN RELIEF CRM is a generic product labeled by AmerisourceBergen, priced at $0.0971 per GM under NDC 46122024403. Its NADAC has been published 159 times since Sep 20, 2023.
Strength
3.5; 10000; 10 mg/g; [USP'U]/g; mg/g
Manufacturer
AmerisourceBergenNDC
46122024403
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M004On Market Since
2/11/2014
Pharmacological Classes
Price Statistics
The NADAC for GNP ANTIBIOTIC-PAIN RELIEF CRM has been published 159 times since Sep 20, 2023, and over the history we have for it it has declined 3.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0971 per GM |
|---|---|
| All-time high | $0.1006 (Apr 10, 2024) |
| All-time low | $0.0903 (Oct 23, 2024) |
| 52-week high | $0.0971 |
| 52-week low | $0.0950 |
| Median price | $0.0971 |
| Average price | $0.0967 |
| Largest weekly change | -7.6% (Oct 23, 2024) |
| Weeks tracked | 159 |
| Tracking since | Sep 20, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Neomycin, Polymyxin B, Pramoxine HCl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Neomycin, Polymyxin B, Pramoxine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoglycoside Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP ANTIBIOTIC-PAIN RELIEF CRM?
The current National Average Drug Acquisition Cost (NADAC) for GNP ANTIBIOTIC-PAIN RELIEF CRM, manufactured by AmerisourceBergen, is $0.0971 per GM (NDC 46122024403), effective Sep 30, 2026.
How has the price of GNP ANTIBIOTIC-PAIN RELIEF CRM changed over time?
Over the history we have for it, the NADAC for GNP ANTIBIOTIC-PAIN RELIEF CRM has declined 3.4%. It has been tracked across 159 weekly CMS publications since Sep 20, 2023.
What are the highest and lowest recorded NADAC prices for GNP ANTIBIOTIC-PAIN RELIEF CRM?
Since Sep 20, 2023, the NADAC for GNP ANTIBIOTIC-PAIN RELIEF CRM has ranged from a low of $0.0903 (Oct 23, 2024) to a high of $0.1006 (Apr 10, 2024), with a median of $0.0971 per GM.
Are there cheaper alternatives to GNP ANTIBIOTIC-PAIN RELIEF CRM?
No other NADAC-published product currently shares the active ingredient and strength of GNP ANTIBIOTIC-PAIN RELIEF CRM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures GNP ANTIBIOTIC-PAIN RELIEF CRM?
GNP ANTIBIOTIC-PAIN RELIEF CRM (NDC 46122024403) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.